UB Paderborn / Katalog / Suche / in CDI

Comparison of structured use of routine laboratory tests or near-patient assessment with clinical judgement in the management of bleeding after cardiac surgery

British journal of anaesthesia : BJA, 2004-02, Vol.92 (2), p.178-186

2004

Volltextzugriff (PDF)

Anticoagulation monitoring during cardiac surgery: A review of current and emerging techniques

Anesthesiology (Philadelphia), 1999-10, Vol.91 (4), p.1122-1151

1999

Volltextzugriff (PDF)

Recombinant human antithrombin III restores heparin responsiveness and decreases activation of coagulation in heparin-resistant patients during cardiopulmonary bypass

The Journal of thoracic and cardiovascular surgery, 2005-07, Vol.130 (1), p.107-113

2005

Volltextzugriff (PDF)

Mechanisms and attenuation of hemostatic activation during extracorporeal circulation

The Annals of thoracic surgery, 2001-11, Vol.72 (5), p.S1821-S1831

2001

Volltextzugriff (PDF)

Factors Associated with Excessive Postoperative Blood Loss and Hemostatic Transfusion Requirements: A Multivariate Analysis in Cardiac Surgical Patients

Anesthesia and analgesia, 1996-01, Vol.82 (1), p.13-21

1996

Volltextzugriff (PDF)

The impact of heparin concentration and activated clotting time monitoring on blood conservation: A prospective, randomized evaluation in patients undergoing cardiac operation

The Journal of thoracic and cardiovascular surgery, 1995-07, Vol.110 (1), p.46-54

1995

Volltextzugriff (PDF)

Use of point-of-care test in identification of patients who can benefit from desmopressin during cardiac surgery: a randomised controlled trial

The Lancet (British edition), 1999-07, Vol.354 (9173), p.106-110

1999

Volltextzugriff (PDF)

Anticoagulation and Anticoagulation Reversal With Cardiac Surgery Involving Cardiopulmonary Bypass: An Update

Journal of cardiothoracic and vascular anesthesia, 1999-08, Vol.13 (4), p.18-29

1999

Volltextzugriff (PDF)

Management approaches to platelet-related microvascular bleeding in cardiothoracic surgery

The Annals of thoracic surgery, 2000-08, Vol.70 (2), p.S20-S32

2000

Volltextzugriff (PDF)

Monitoring of hemostasis in cardiac surgical patients: impact of point-of-care testing on blood loss and transfusion outcomes

Clinical chemistry (Baltimore, Md.), 1997-09, Vol.43 (9), p.1684-1696

1997

Volltextzugriff (PDF)

Prospective evaluation and clinical utility of on-site monitoring of coagulation in patients undergoing cardiac operation

The Journal of thoracic and cardiovascular surgery, 1994-01, Vol.107 (1), p.271-279

1994

Volltextzugriff (PDF)

Comparison of activated coagulation time and whole blood heparin measurements with laboratory plasma anti-Xa heparin concentration in patients having cardiac operations

The Journal of thoracic and cardiovascular surgery, 1994-12, Vol.108 (6), p.1076-1082

1994

Volltextzugriff (PDF)

The effect of an intraoperative treatment algorithm on physicians' transfusion practice in cardiac surgery

Transfusion (Philadelphia, Pa.), 1994-04, Vol.34 (4), p.290-296

1994

Volltextzugriff (PDF)

Antithrombin III During Cardiac Surgery: Effect on Response of Activated Clotting Time to Heparin and Relationship to Markers of Hemostatic Activation

Anesthesia and analgesia, 1997-09, Vol.85 (3), p.498-506

1997

Volltextzugriff (PDF)

Uses of antithrombin III concentrate in congenital and acquired deficiency states

Transfusion (Philadelphia, Pa.), 1998-05, Vol.38 (5), p.481-498

1998

Volltextzugriff (PDF)

Evaluation of a new point-of-care test that measures PAF-mediated acceleration of coagulation in cardiac surgical patients

Anesthesiology (Philadelphia), 1996-12, Vol.85 (6), p.1311-1323

1996

Volltextzugriff (PDF)

On the need for improved transfusion indicators in cardiac surgery

The Annals of thoracic surgery, 1995-08, Vol.60 (2), p.473-480

1995

Volltextzugriff (PDF)

Whole blood heparin concentration measurements by automated protamine titration agree with plasma anti-Xa measurements

The Journal of thoracic and cardiovascular surgery, 1997-03, Vol.113 (3), p.611-613

1997

Volltextzugriff (PDF)

On-site prothrombin time, activated partial thromboplastin time, and platelet count : a comparison between whole blood and laboratory assays with coagulation factor analysis in patients presenting for cardiac surgery

Anesthesiology (Philadelphia), 1994-02, Vol.80 (2), p.338-351

1994

Volltextzugriff (PDF)

A Randomized Trial of Acute Normovolemic Hemodilution Compared to Preoperative Autologous Blood Donation in Total Knee Arthroplasty

Vox sanguinis, 1999-08, Vol.77 (1), p.11-16

1999

Volltextzugriff (PDF)

Heparin resistance and the potential impact on maintenance of therapeutic coagulation

European journal of anaesthesiology, 2007-06, Vol.24 (S40), p.37-58

2007

Volltextzugriff (PDF)

Aprotinin Prolongs Activated and Nonactivated Whole Blood Clotting Time and Potentiates the Effect of Heparin In Vitro

Anesthesia and analgesia, 1996-06, Vol.82 (6), p.1126-1131

1996

Volltextzugriff (PDF)

Clinical evaluation of a new, point-of-care hemocytometer

Critical care medicine, 2000-04, Vol.28 (4), p.1185-1190

2000

Volltextzugriff (PDF)

Aprotinin Prolongs Whole Blood Activated Partial Thromboplastin Time but Not Whole Blood Prothrombin Time in Patients Undergoing Cardiac Surgery

Anesthesia and analgesia, 1995-11, Vol.81 (5), p.919-924

1995

Volltextzugriff (PDF)

Preoperative use of enoxaparin and tirofiban : Possible association with increased bleeding postbypass

Anesthesiology (Philadelphia), 1999-09, Vol.91 (3), p.869-872

1999

Volltextzugriff (PDF)

Menü

Weitere Dienste

Einstellungen

Comparison of structured use of routine laboratory tests or near-patient assessment with clinical judgement in the management of bleeding after cardiac surgery

Anticoagulation monitoring during cardiac surgery: A review of current and emerging techniques

Recombinant human antithrombin III restores heparin responsiveness and decreases activation of coagulation in heparin-resistant patients during cardiopulmonary bypass

Mechanisms and attenuation of hemostatic activation during extracorporeal circulation

Factors Associated with Excessive Postoperative Blood Loss and Hemostatic Transfusion Requirements: A Multivariate Analysis in Cardiac Surgical Patients

The impact of heparin concentration and activated clotting time monitoring on blood conservation: A prospective, randomized evaluation in patients undergoing cardiac operation

Use of point-of-care test in identification of patients who can benefit from desmopressin during cardiac surgery: a randomised controlled trial

Anticoagulation and Anticoagulation Reversal With Cardiac Surgery Involving Cardiopulmonary Bypass: An Update

Management approaches to platelet-related microvascular bleeding in cardiothoracic surgery

Monitoring of hemostasis in cardiac surgical patients: impact of point-of-care testing on blood loss and transfusion outcomes

Prospective evaluation and clinical utility of on-site monitoring of coagulation in patients undergoing cardiac operation

Comparison of activated coagulation time and whole blood heparin measurements with laboratory plasma anti-Xa heparin concentration in patients having cardiac operations

The effect of an intraoperative treatment algorithm on physicians' transfusion practice in cardiac surgery

Antithrombin III During Cardiac Surgery: Effect on Response of Activated Clotting Time to Heparin and Relationship to Markers of Hemostatic Activation

Uses of antithrombin III concentrate in congenital and acquired deficiency states

Evaluation of a new point-of-care test that measures PAF-mediated acceleration of coagulation in cardiac surgical patients

On the need for improved transfusion indicators in cardiac surgery

Whole blood heparin concentration measurements by automated protamine titration agree with plasma anti-Xa measurements

On-site prothrombin time, activated partial thromboplastin time, and platelet count : a comparison between whole blood and laboratory assays with coagulation factor analysis in patients presenting for cardiac surgery

A Randomized Trial of Acute Normovolemic Hemodilution Compared to Preoperative Autologous Blood Donation in Total Knee Arthroplasty

Heparin resistance and the potential impact on maintenance of therapeutic coagulation

Aprotinin Prolongs Activated and Nonactivated Whole Blood Clotting Time and Potentiates the Effect of Heparin In Vitro

Clinical evaluation of a new, point-of-care hemocytometer

Aprotinin Prolongs Whole Blood Activated Partial Thromboplastin Time but Not Whole Blood Prothrombin Time in Patients Undergoing Cardiac Surgery

Preoperative use of enoxaparin and tirofiban : Possible association with increased bleeding postbypass

Suchergebnisse filtern